PHK
EBS icon

Point72 Hong Kong’s Emergent Biosolutions EBS Stock Holding History

Point72 Hong Kong’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-513
Closed -$16K – 2038
2022
Q2 		$16K Sell
513
-3,187
-86% -$109K ﹤0.01% 1597
2022
Q1 		$152K Sell
3,700
-1,721
-32% -$75.9K 0.01% 1042
2021
Q4 		$236K Buy
5,421
+3,305
+156% +$150K 0.01% 976
2021
Q3 		$106K Buy
+2,116
New +$128K ﹤0.01% 1329
2020
Q4 		– Sell
-575
Closed -$59K – 1797
2020
Q3 		$59K Buy
+575
New +$62K 0.01% 652
2020
Q1 		– Sell
-1,271
Closed -$69K – 1049
2019
Q4 		$69K Buy
+1,271
New +$68.9K 0.02% 613
2019
Q1 		– Sell
-2,180
Closed -$129K – 1086
2018
Q4 		$129K Buy
+2,180
New +$141K 0.06% 148
2018
Q2 		– Sell
-549
Closed -$29K – 960
2018
Q1 		$29K Buy
+549
New +$27.4K 0.02% 566
2017
Q1 		– Sell
-130
Closed -$4K – 786
2016
Q4 		$4K Buy
+130
New +$3.9K ﹤0.01% 730

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Point72 Hong Kong's EBS Position: Q3 2022 in Review

Point72 Hong Kong sold out of Emergent Biosolutions (EBS) in Q3 2022, closing a stake of 513 shares — an estimated $16K sold.

Point72 Hong Kong first reported a position in EBS in Q4 2016 and held it in 9 quarters. The position peaked at $236K in Q4 2021. 211 funds tracked by Wall St. Rank hold EBS as of Q3 2022.

  • Point72 Hong Kong reported no remaining Emergent Biosolutions position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 513 Emergent Biosolutions shares in Q3 2022, an estimated $16K.
  • Point72 Hong Kong first reported a position in Emergent Biosolutions in Q4 2016 and held it in 9 quarters.
  • Point72 Hong Kong's Emergent Biosolutions position peaked at $236K in Q4 2021.
  • 211 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.